MIRA
INFORM REPORT
|
Report Date : |
08.05.2007 |
IDENTIFICATION DETAILS
|
Name : |
SEWA MEDICALS LIMITED |
|
|
|
|
Registered Office : |
10/11 Prospect chambers Annex, 317/21, DR D N RD Fort, Mumbai, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2002 |
|
|
|
|
Date of Incorporation : |
09.12.1993 |
|
|
|
|
Com. Reg. No.: |
054451 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U99999MH1993PTC054451 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMS41612E |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACS7913D |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. The sompany is a sick
Unit. |
|
|
|
|
Line of Business : |
Manufacturer and Exporters of Hypodermic Glass Syringes |
RATING & COMMENTS
|
MIRA’s Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not recommended |
|
Maximum Credit Limit : |
-- |
|
|
|
|
Status : |
Sick Company |
|
|
|
|
Payment Behaviour : |
Delayed |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
The company networths has been eroded. It is a sick Industrial Unit
under Boardof industrial Financial and Reconstruction . The Compnay’s
payments are slow and Delayed. It has not prepared up-to-date financial. we are trying for more
business and financial details from Mr. Harsh Shandoliya and Mr. Ramesh
Gandhi. If they provide we shall update the same. In the mean time, it is learnt that company’s annual sales is of
Rs.60.000 Millions As claimed, the company has substantial order in hand but due to
working capitals shortage, they are not in a position to meet further orders. It was gathered that Cosmos Cooperative Bank has Withdrawn as a
banker. The company can be considered for any business dealings on safe and
secured trade terms and conditions |
LOCATIONS
|
Registered Office : |
10/11 Prospect Chambers Annex, 317/21, DR D N RD Fort, |
|
Tel. No.: |
91-22-6520-6102/6103/ 8849/ 8850 |
|
Fax No.: |
91-22-2204-5352 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Rented |
|
|
|
|
Factory 1 : |
Gut No.229 - 232,Alandi Markal
Road, Village Markal Taluka Khed, Taluka : Khed, Dist : PUNE PIN - 412105 |
|
E-Mail : |
DIRECTORS
|
Name : |
Mr. Kirit Shandaliya |
|
Designation : |
Directors |
|
|
|
|
Name : |
Mr. Harsh Shandiya |
|
Designation : |
Directors |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporters of Hypodermic Glass Syringes |
|
|
|
|
Products : |
Syringe , Medicals |
|
|
|
|
Exports : |
|
|
Products : |
Glass Syringes |
|
Countries : |
|
|
|
|
|
Imports : |
|
|
Products : |
Raw Materials |
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Credit |
|
|
|
|
Purchasing : |
Cash |
GENERAL INFORMATION
|
Customers : |
Wholesalers, Retailers and Endusers |
|
|
|
|
No. of Employees : |
Total:220 (Office:20, factory:200) |
|
|
|
|
Bankers : |
Cosmos Bank, Mumbai (No More A/c) Canara Bank, Mumbai |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking
Relations : |
Poor |
|
|
|
|
Associates/Subsidiaries : |
Top Syrinse Manufacturing Company Mumbia Tempo Instrumetns Equipmetns Capital Private Limited, Mumbai |
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
|
31.03.2007 |
|
Sales Turnover |
|
|
60.000 |
ABRIDGED BALANCE SHEET
|
SOURCES OF FUNDS |
|
31.03.2002 |
31.03.2001 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
71.712 |
71.712 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
200.744 |
0.000 |
|
|
4] (Accumulated Losses) |
|
(394.335) |
(54.161) |
|
|
NETWORTH |
|
(121.879) |
17.551 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
926.096 |
776.764 |
|
|
2] Unsecured Loans |
|
0.000 |
0.000 |
|
|
TOTAL BORROWING |
|
926.096 |
776.764 |
|
|
DEFERRED TAX LIABILITIES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
804.217 |
794.315 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
684.683 |
664.230 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
1.502 |
1.502 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Other Current Assets |
|
132.377 |
132.869 |
|
Total
Current Assets |
|
132.377 |
132.869 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
14.345 |
4.287 |
|
|
Provisions |
|
0.000 |
0.000 |
|
Total
Current Liabilities |
|
14.345 |
4.287 |
|
|
Net Current Assets |
|
118.032 |
128.583 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
804.217 |
794.315 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2002 |
31.03.2001 |
|
|
Sales Turnover |
|
84.199 |
15.116 |
|
|
Other Income |
|
|
|
|
|
Total Income |
|
84.199 |
15.116 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
(139.429) |
(116.600) |
|
|
Provision for Taxation |
|
0.000 |
0.000 |
|
|
Profit/(Loss) After Tax |
|
(139.429) |
(116.600) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Salaries, Wages, Bonus, etc. |
|
9.270 |
7.589 |
|
|
Interest |
|
98.510 |
134.513 |
|
Total Expenditure |
|
107.780 |
142.102 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2002 |
31.03.2001 |
|
PAT / Total Income |
(%) |
|
(0.16) |
(7.71) |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
(0.16) |
(7.71) |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
(17.06) |
(14.62) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
(1.14) |
(6.64) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
0.11 |
0.24 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
9.22 |
30.99 |
LOCAL AGENCY FURTHER INFORMATION
Financial:
The company has not filed financial subsequent to 2002. It is a sick
Industrial Unit.
As Per Web Site:
About the Company
:
The Shandilya group has been one of the pioneers in
They manufacture Hypodermic Glass Syringes in standard sizes and our
speciality is to convert glass tubes into various products with precision
finish.
Company has setup a modern factory on the outskirts of
A comapny, is a medical technology company that caters to the needs of
Pharma companies, Scientific & Clinical laboratories, and ophthalmic
surgery
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.40.91 |
|
|
1 |
Rs.81.46 |
|
Euro |
1 |
Rs.55.42 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|